Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Exome sequencing: value is in the eye of the beholder.

Grosse SD, Rasmussen SA.

Genet Med. 2019 Oct 14. doi: 10.1038/s41436-019-0674-z. [Epub ahead of print] No abstract available.

PMID:
31607748
2.

Avoiding Harm From Hyperbilirubinemia Screening-Reply.

Grosse SD, Prosser LA, Botkin JR.

JAMA Pediatr. 2019 Oct 7. doi: 10.1001/jamapediatrics.2019.3762. [Epub ahead of print] No abstract available.

PMID:
31589244
3.

Data needed to respond appropriately to anemia when it is a public health problem.

Williams AM, Addo OY, Grosse SD, Kassebaum NJ, Rankin Z, Ballesteros KE, Olsen HE, Sharma AJ, Jefferds ME, Mei Z.

Ann N Y Acad Sci. 2019 Aug;1450(1):268-280. doi: 10.1111/nyas.14175. Epub 2019 Jul 2.

PMID:
31267542
4.

Screening for Neonatal Hyperbilirubinemia-First Do No Harm?

Grosse SD, Prosser LA, Botkin JR.

JAMA Pediatr. 2019 Jul 1;173(7):617-618. doi: 10.1001/jamapediatrics.2019.1194. No abstract available.

PMID:
31107538
5.

A practical guide to episode groupers for cost-of-illness analysis in health services research.

Peterson C, Grosse SD, Dunn A.

SAGE Open Med. 2019 Mar 29;7:2050312119840200. doi: 10.1177/2050312119840200. eCollection 2019. Review.

6.

Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time.

Grosse SD, Pike J, Soelaeman R, Tilford JM.

Pharmacoeconomics. 2019 Apr;37(4):461-473. doi: 10.1007/s40273-019-00782-9. Review.

7.

Assessing the Hereditary Hemorrhagic Telangiectasia Algorithms in a Community-Based Patient Population.

Saparia T, Faughnan ME, Schneider JL, Almers LM, Chow N, Grosse SD, Kim H, Zaroff JG.

Perm J. 2019;23. pii: 18-145. doi: 10.7812/TPP/18-145.

8.

Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources.

Okolo AI, Soucie JM, Grosse SD, Roberson C, Janson IA, Allen M, Shapiro AD.

Haemophilia. 2019 May;25(3):456-462. doi: 10.1111/hae.13734. Epub 2019 Mar 29.

PMID:
30924993
9.

Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada.

Karaceper MD, Khangura SD, Wilson K, Coyle D, Brownell M, Davies C, Dodds L, Feigenbaum A, Fell DB, Grosse SD, Guttmann A, Hawken S, Hayeems RZ, Kronick JB, Laberge AM, Little J, Mhanni A, Mitchell JJ, Nakhla M, Potter M, Prasad C, Rockman-Greenberg C, Sparkes R, Stockler S, Ueda K, Vallance H, Wilson BJ, Chakraborty P, Potter BK; Canadian Inherited Metabolic Diseases Research Network (CIMDRN).

Orphanet J Rare Dis. 2019 Mar 22;14(1):70. doi: 10.1186/s13023-019-1001-0.

10.

Correction.

Grosse SD, Krueger KV, Pike J.

J Med Econ. 2019 Jun;22(6):612. doi: 10.1080/13696998.2019.1584497. Epub 2019 Mar 1. No abstract available.

PMID:
30821543
11.

Actions in Support of Newborn Screening for Critical Congenital Heart Disease - United States, 2011-2018.

Glidewell J, Grosse SD, Riehle-Colarusso T, Pinto N, Hudson J, Daskalov R, Gaviglio A, Darby E, Singh S, Sontag M.

MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):107-111. doi: 10.15585/mmwr.mm6805a3.

12.

Cystic Fibrosis And Ivacaftor Use: The Authors Reply.

Feng LB, Grosse SD, Sawicki GS.

Health Aff (Millwood). 2019 Feb;38(2):328. doi: 10.1377/hlthaff.2018.05268. No abstract available.

13.

US State-Level Infertility Insurance Mandates and Health Plan Expenditures on Infertility Treatments.

Boulet SL, Kawwass J, Session D, Jamieson DJ, Kissin DM, Grosse SD.

Matern Child Health J. 2019 May;23(5):623-632. doi: 10.1007/s10995-018-2675-y.

PMID:
30600516
14.

Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.

Grosse SD, Krueger KV, Pike J.

J Med Econ. 2019 Jun;22(6):501-508. doi: 10.1080/13696998.2018.1542520. Epub 2018 Nov 15. Erratum in: J Med Econ. 2019 Mar 1;:1.

PMID:
30384792
15.

Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016.

Grosse SD, Do TQN, Vu M, Feng LB, Berry JG, Sawicki GS.

Pediatr Pulmonol. 2018 Dec;53(12):1611-1618. doi: 10.1002/ppul.24178. Epub 2018 Oct 31.

PMID:
30381911
16.

Adherence to Recommended Care Guidelines in the Treatment of Preschool-Age Medicaid-Enrolled Children With a Diagnosis of ADHD.

Moran A, Serban N, Danielson ML, Grosse SD, Cuffe SP.

Psychiatr Serv. 2019 Jan 1;70(1):26-34. doi: 10.1176/appi.ps.201800204. Epub 2018 Oct 30.

17.

What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?

Grosse SD, Mason CA, Gaffney M, Thomson V, White KR.

Int J Neonatal Screen. 2018;4(3):25. doi: 10.3390/ijns4030025. Epub 2018 Jul 20.

18.

Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.

Prosser LA, Lam KK, Grosse SD, Casale M, Kemper AR.

MDM Policy Pract. 2018 Jan-Jun;3(1). doi: 10.1177/2381468318763814. Epub 2018 Apr 18.

19.

Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?

Grosse SD, Farnaes L.

Genet Med. 2019 Feb;21(2):269-271. doi: 10.1038/s41436-018-0124-3. Epub 2018 Aug 13. No abstract available.

PMID:
30100610
20.

Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.

Pike J, Grosse SD.

Appl Health Econ Health Policy. 2018 Dec;16(6):765-778. doi: 10.1007/s40258-018-0416-4. Review.

21.

Is universal tumor testing for Lynch syndrome cost-effective? It depends!

Grosse SD.

Genet Med. 2019 Jan;21(1):252-253. doi: 10.1038/s41436-018-0025-5. Epub 2018 May 15. No abstract available.

22.

Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

Feng LB, Grosse SD, Green RF, Fink AK, Sawicki GS.

Health Aff (Millwood). 2018 May;37(5):773-779. doi: 10.1377/hlthaff.2017.1554.

23.

Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009-2015.

Leung J, Dollard SC, Grosse SD, Chung W, Do T, Patel M, Lanzieri TM.

Clin Ther. 2018 Mar;40(3):430-439.e1. doi: 10.1016/j.clinthera.2018.01.006. Epub 2018 Feb 4.

24.

Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.

Grosse SD, Peterson C, Abouk R, Glidewell J, Oster ME.

Int J Neonatal Screen. 2017;3(4):34. doi: 10.3390/ijns3040034. Epub 2017 Dec 14.

25.

Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.

Carias C, Chesson HW, Grosse SD, Li R, Meltzer MI, Miller GF, Murphy LB, Nurmagambetov TA, Pike JJ, Whitham HK.

Am J Prev Med. 2018 Apr;54(4):600-602. doi: 10.1016/j.amepre.2017.11.013. Epub 2018 Jan 12. No abstract available.

26.

Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths.

Abouk R, Grosse SD, Ailes EC, Oster ME.

JAMA. 2017 Dec 5;318(21):2111-2118. doi: 10.1001/jama.2017.17627. Erratum in: JAMA. 2018 Sep 25;320(12):1288.

27.

How Economic Findings Can Inform Prevention Research in Cardiovascular Disease.

Grosse SD.

Am J Prev Med. 2017 Dec;53(6 Suppl 2):S118-S120. doi: 10.1016/j.amepre.2017.08.013. No abstract available.

28.

Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health.

Wang G, Grosse SD, Schooley MW.

Am J Prev Med. 2017 Dec;53(6 Suppl 2):S115-S117. doi: 10.1016/j.amepre.2017.08.005. No abstract available.

29.

In Reference to: "Cost and Utility of Thrombophilia Testing".

Berse B, Lynch JA, Bowen S, Grosse SD.

J Hosp Med. 2017 Sep;12(9):783. doi: 10.12788/jhm.2818. No abstract available.

30.

Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.

Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.

Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.

PMID:
28933789
31.

Employer-Sponsored Plan Expenditures for Infants Born Preterm.

Grosse SD, Waitzman NJ, Yang N, Abe K, Barfield WD.

Pediatrics. 2017 Oct;140(4). pii: e20171078. doi: 10.1542/peds.2017-1078.

32.

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.

33.

CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease.

Grosse SD, Riehle-Colarusso T, Gaffney M, Mason CA, Shapira SK, Sontag MK, Braun KVN, Iskander J.

MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):888-890. doi: 10.15585/mmwr.mm6633a4.

34.

Prophylaxis use among males with haemophilia B in the United States.

Ullman M, Zhang QC, Grosse SD, Recht M, Soucie JM; Hemophilia Treatment Center Network Investigators.

Haemophilia. 2017 Nov;23(6):910-917. doi: 10.1111/hae.13317. Epub 2017 Aug 6.

35.

Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.

Grosse SD, Gurrin LC, Bertalli NA, Allen KJ.

Genet Med. 2018 Apr;20(4):383-389. doi: 10.1038/gim.2017.121. Epub 2017 Aug 3. Review.

36.

Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?

Lain S, Trumpff C, Grosse SD, Olivieri A, Van Vliet G.

Eur J Endocrinol. 2017 Nov;177(5):D1-D12. doi: 10.1530/EJE-17-0107. Epub 2017 Jul 10. Review.

37.

The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.

Soucie JM, Grosse SD, Siddiqi AE, Byams V, Thierry J, Zack MM, Shapiro A, Duncan N; Hemophilia Treatment Centers Network.

Haemophilia. 2017 Jul;23(4):e287-e293. doi: 10.1111/hae.13275. Epub 2017 Jun 2.

38.

Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.

Nyarko KA, Grosse SD, Danielson ML, Holbrook JR, Visser SN, Shapira SK.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):731-734. doi: 10.1089/cap.2016.0196. Epub 2017 Mar 22.

39.

Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, Grosse SD, Miller JA, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Mar;139(3). pii: e20162610. doi: 10.1542/peds.2016-2610. Epub 2017 Feb 16.

40.

Accounting for differences in healthcare utilization and expenditures among US males with haemophilia by type of health insurance.

Guh S, Grosse SD, Ullman M, Soucie JM.

Haemophilia. 2017 Mar;23(2):e147-e151. doi: 10.1111/hae.13161. Epub 2017 Feb 2. No abstract available.

41.

Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.

Grosse SD, Lam WKK, Wiggins LD, Kemper AR.

Genet Med. 2017 Sep;19(9):975-982. doi: 10.1038/gim.2016.223. Epub 2017 Jan 26. Review.

42.

Screening for Congenital Cytomegalovirus After Newborn Hearing Screening: What Comes Next?

Grosse SD, Dollard SC, Kimberlin DW.

Pediatrics. 2017 Feb;139(2). pii: e20163837. doi: 10.1542/peds.2016-3837. No abstract available.

43.

Inpatient Hospitalization Costs Associated with Birth Defects Among Persons of All Ages - United States, 2013.

Arth AC, Tinker SC, Simeone RM, Ailes EC, Cragan JD, Grosse SD.

MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):41-46. doi: 10.15585/mmwr.mm6602a1.

44.

Databases for Congenital Heart Defect Public Health Studies Across the Lifespan.

Riehle-Colarusso TJ, Bergersen L, Broberg CS, Cassell CH, Gray DT, Grosse SD, Jacobs JP, Jacobs ML, Kirby RS, Kochilas L, Krishnaswamy A, Marelli A, Pasquali SK, Wood T, Oster ME; Congenital Heart Public Health Consortium.

J Am Heart Assoc. 2016 Oct 26;5(11). pii: e004148. Review. No abstract available.

45.

Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.

Dunn A, Grosse SD, Zuvekas SH.

Health Serv Res. 2018 Feb;53(1):175-196. doi: 10.1111/1475-6773.12612. Epub 2016 Nov 21. Review.

46.

Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016.

Li R, Simmons KB, Bertolli J, Rivera-Garcia B, Cox S, Romero L, Koonin LM, Valencia-Prado M, Bracero N, Jamieson DJ, Barfield W, Moore CA, Mai CT, Korhonen LC, Frey MT, Perez-Padilla J, Torres-Muñoz R, Grosse SD.

Emerg Infect Dis. 2017 Jan;23(1):74-82. doi: 10.3201/eid2301.161322. Epub 2017 Jan 15.

47.

The need for a next-generation public health response to rare diseases.

Valdez R, Grosse SD, Khoury MJ.

Genet Med. 2016 Oct 27;19(5):489-490. doi: 10.1038/gim.2016.166. Epub 2016 Oct 27. No abstract available.

48.

Venous thromboembolism and subsequent permanent work-related disability.

Braekkan SK, Grosse SD, Okoroh EM, Tsai J, Cannegieter SC, Naess IA, Krokstad S, Hansen JB, Skjeldestad FE.

J Thromb Haemost. 2016 Oct;14(10):1978-1987. doi: 10.1111/jth.13411. Epub 2016 Aug 17.

49.

Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.

Grosse SD, Khoury MJ.

Genet Med. 2016 Oct;18(10):963-5. doi: 10.1038/gim.2016.121. Epub 2016 Sep 8. No abstract available.

50.

Correction: Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010.

Dupervil BM, Grosse SD, Burnett AL, Parker CS.

PLoS One. 2016 Aug 24;11(8):e0162056. doi: 10.1371/journal.pone.0162056. eCollection 2016.

Supplemental Content

Loading ...
Support Center